Zhittya believes vascular disruption and micro-vessel disease in the brain is a major contributor to neurodegenerative diseases, such as Parkinson’s disease. They hope to start human clinical trials in 2019.
The first place hey will post the FDA-authorized inclusion and exclusion criteria will be on Zhittya’s YouTube channel. if you are not subscribed to Zhittya’s YouTube channel you can go to:
Parkinson’s News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.